Medicare Enrolled
Dr. Daniel Berry, MD
Internal Medicine · Clyde, OH
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Berry from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Berry?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Berry
Dr. Daniel Berry is an internal medicine specialist in Clyde, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Berry performed 3,789 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Berry received a total of $19,694 from 60 pharmaceutical and/or device companies across 1062 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Berry is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 4% volume in OH
$19,694 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,789
Medicare services
Top 4% in OH for internal medicine
Not available
Unique patients (not deduplicated)
$46
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 1,320 | $18 | $65 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
551 | $62 | $175 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
325 | $89 | $240 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
244 | $50 | $160 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
228 | $58 | $185 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
157 | $125 | $235 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
124 | $76 | $155 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
116 | $1 | $10 |
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
113 | $140 | $305 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
110 | $10 | $30 |
| Annual alcohol misuse screening, 5 to 15 minutes | 107 | $18 | $44 |
| Annual depression screening | 106 | $18 | $30 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
58 | $9 | $65 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
42 | $37 | $150 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
42 | $29 | $46 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
38 | $72 | $180 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
35 | $3 | $10 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
22 | $153 | $350 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
21 | $136 | $370 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
16 | $10 | $70 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
14 | $35 | $120 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$19,694
Total received (2018-2024)
Avg $2,813/year across 7 years
Top 4% in OH for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
1,062
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,791
2023
$2,196
2022
$3,175
2021
$2,563
2020
$1,468
2019
$3,464
2018
$4,037
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$806
ABBVIE INC.
$468
Novo Nordisk Inc
$296
Teva Pharmaceuticals USA, Inc.
$221
PFIZER INC.
$192
Avadel CNS Pharmaceuticals, LLC
$117
Abbott Laboratories
$88
Phathom Pharmaceuticals, Inc.
$88
Otsuka America Pharmaceutical, Inc.
$78
Bayer Healthcare Pharmaceuticals Inc.
$74
GlaxoSmithKline, LLC.
$55
Dexcom, Inc.
$53
Lundbeck LLC
$52
Lilly USA, LLC
$32
Vanda Pharmaceuticals Inc.
$28
Astellas Pharma US Inc
$22
Novartis Pharmaceuticals Corporation
$20
Antares Pharma, Inc.
$20
Seqirus USA Inc
$18
Neurocrine Biosciences, Inc.
$18
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$17
Alkermes, Inc.
$15
ACADIA Pharmaceuticals Inc
$14
Top 3 companies account for 56.3% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,662
Novo Nordisk Inc
$2,039
Janssen Pharmaceuticals, Inc
$1,613
Amgen Inc.
$1,425
GlaxoSmithKline, LLC.
$1,013
ABBVIE INC.
$823
AbbVie Inc.
$802
PFIZER INC.
$795
Lilly USA, LLC
$770
Novartis Pharmaceuticals Corporation
$675
Teva Pharmaceuticals USA, Inc.
$628
Biohaven Pharmaceutical Holding Company Ltd.
$587
Merck Sharp & Dohme Corporation
$482
Boehringer Ingelheim Pharmaceuticals, Inc.
$441
SANOFI-AVENTIS U.S. LLC
$434
Biohaven Pharmaceuticals, Inc.
$410
Astellas Pharma US Inc
$312
Otsuka America Pharmaceutical, Inc.
$302
Ironwood Pharmaceuticals, Inc
$278
E.R. Squibb & Sons, L.L.C.
$260
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$241
Bayer HealthCare Pharmaceuticals Inc.
$238
Takeda Pharmaceuticals U.S.A., Inc.
$238
Allergan Inc.
$215
Amarin Pharma Inc.
$183
Allergan, Inc.
$147
Esperion Therapeutics, Inc.
$144
Merck Sharp & Dohme LLC
$132
Bayer Healthcare Pharmaceuticals Inc.
$126
Avadel CNS Pharmaceuticals, LLC
$117
Abbott Laboratories
$108
Alkermes, Inc.
$105
Corcept Therapeutics
$98
Phathom Pharmaceuticals, Inc.
$88
Dexcom, Inc.
$87
Lundbeck LLC
$64
Scilex Pharmaceuticals Inc.
$60
Avanir Pharmaceuticals, Inc.
$51
NESTLE HEALTHCARE NUTRITION INC.
$46
Mylan Specialty L.P.
$41
Horizon Therapeutics plc
$39
Gilead Sciences, Inc.
$36
Kowa Pharmaceuticals America, Inc.
$31
Eisai Inc.
$30
ACADIA Pharmaceuticals Inc
$28
Shire North American Group Inc
$28
Vanda Pharmaceuticals Inc.
$28
Kyowa Kirin, Inc.
$25
Antares Pharma, Inc.
$20
Seqirus USA Inc
$18
Neurocrine Biosciences, Inc.
$18
Shield Therapeutics Inc
$18
Horizon Pharma plc
$16
Xeris Pharmaceuticals, Inc.
$13
Clarus Therapeutics Inc.
$13
Alfasigma USA, Inc.
$13
IDORSIA PHARMACEUTICALS US INC
$13
Upsher-Smith Laboratories LLC
$12
Regeneron Healthcare Solutions, Inc.
$11
Sumitomo Pharma America, Inc.
$1
Top 3 companies account for 32.1% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ACCRUFER · AIMOVIG · AIRSUPRA · AJOVY · ANORO · ANORO ELLIPTA · ARISTADA · AUSTEDO · Aimovig · Amitiza · Austedo XR · BAQSIMI · BASAGLAR · BELSOMRA · BREZTRI · BREZTRI AEROSPHERE · BYDUREON · BYSTOLIC · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · CREON · DUZALLO · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · FARXIGA · FLULAVAL · FREESTYLE LIBRE 3 · Flucelvax · FreeStyle Libre · GEMTESA · GVOKE HYPOPEN · HETLIOZ · HUMALOG · INGREZZA · INVOKANA · JANUVIA · JARDIANCE · JATENZO · KRYSTEXXA · Kerendia · Korlym · LANTUS · LEQVIO · LINZESS · LOKELMA · LUMRYZ · LYBALVI · LYRICA · MOUNJARO · MYDAYIS · MYRBETRIQ · NEXLETOL · NEXLIZET · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Otezla · Ozempic · PENNSAID · PRALUENT · PREVNAR 20 · Prolia · QULIPTA · QUVIVIQ · REXULTI · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · Saxenda · Seglentis · TOSYMRA SUMATRIPTAN NASAL SPRAY · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Tresiba · Trintellix · UBRELVY · VIBERZI · VIIBRYD · VOQUEZNA · VOWST · VPRIV · VRAYLAR · Vascepa · Veklury · Veozah · Victoza · Vyvanse · Wegovy · XARELTO · XIFAXAN · XYOSTED · Xultophy 100/3.6 · Yupelri · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Internal medicine physicians in nearby ZIP areas
51
County median income
$62,500
Nearest hospital to ZIP centroid (approximate)
BELLEVUE HOSPITAL
7.3 mi
7.3 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Berry is a clinical cardiology specialist, with above-average Medicare volume (top 4% in OH), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Berry experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Berry performed 1,320 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Berry receive payments from pharmaceutical companies?
Yes. Dr. Berry received a total of $19,694 from 60 companies across 1,062 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Berry's costs compare to other internal medicine physicians in Clyde?
Dr. Berry's average Medicare payment per service is $46. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Berry) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Clyde
Browse internal medicine physicians in Clyde ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in OH
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in OH
Which OH internal medicine physicians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology